Back to search results

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Abroad (travel likely)RecruitingPHASE3

Conditions

Diabetes Mellitus, Type 1 · Impaired Hypoglycemic Awareness · Severe Hypoglycemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope, Duarte, California, United States

  • University of California San Francisco, San Francisco, California, United States

  • UHealth Diabetes Research Institute, Miami, Florida, United States

  • Northwestern Organ Transplant Center, Chicago, Illinois, United States

  • University of Chicago, Chicago, Illinois, United States

  • Johns Hopkins University, Baltimore, Maryland, United States

  • Massachusetts General Hospital, Boston, Massachusetts, United States

  • Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

  • University of Pittsburgh Medical Center Montefiore, Pittsburgh, Pennsylvania, United States

  • Baylor Scott and White Research Institute, Dallas, Texas, United States

  • VCU Medical Center, Richmond, Richmond, Virginia, United States

  • University of Wisconsin, Madison, Wisconsin, United States

  • University of Alberta, Edmonton, Edmonton, Canada

  • McGill University Health Centre, Montreal, Canada

  • Toronto General Hospital (TGH), Toronto, Canada

  • Vancouver General Hospital, Vancouver, Canada

  • CHU Lille, Lille, France

  • Centre de recherche en Biomédecine de Strasbourg, Strasbourg, France

  • Dresden Center for Islet Transplantation, Dresden, Germany

  • IRCCS Ospedale San Raffaele, Milan, Italy

  • Leiden University, Leiden, Netherlands

  • Oslo University Hospital, Oslo, Norway

  • King Abdullah International Medical Research Center (KAIMRC) - Riyadh - Endocrinology, Riyadh, Saudi Arabia

  • King Faisal Specialist Hospital & Research Centre - Riyadh - Endocrinology, Riyadh, Saudi Arabia

  • Hopiteaux Universitaires de Geneve, Geneva, Switzerland

  • Churchill Hospital, Headington, Oxford, United Kingdom

  • Royal Infirmary of Edinburgh, Edinburgh, United Kingdom

  • Cardiovascular, Metabolic Medicine and Sciences, King's College London, London, United Kingdom

  • The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)